Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
PaperCitations, authors & open-access status
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 187 citations, 2017 year and closed oa status.
187
Citations
2017
Year
closed
OA Status